SCHEMBL166667

SCHEMBL166667

C=CN(CC(=O)O)OCCN

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CTH P32929 1/20 0.31
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3260596 0.77 PLA2G2A (0.41) BLMHSD17B10
SCHEMBL8735298 0.76 TDP1 (0.31) BLMPMP22LMNA
Ammonia Solution, Strong SCHEMBL27472350 0.74 EYA2 (0.30)
SCHEMBL165060 0.71
SCHEMBL4013690 0.68
SCHEMBL3076022 0.68 SLC6A2 (0.33) BLM
SCHEMBL5528134 0.65 TDP1 (0.37) BLMPMP22HSD17B10LMNA
SCHEMBL2993739 0.65
Nitrilotriacetic Acid SCHEMBL19893757 0.64 TDP1 (0.58) BLMPMP22HSD17B10LMNA
SCHEMBL8076843 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115067357-A Composite fruit setting agent and application thereof in sweet cherry planting 青岛市农业科学研究院 2022-09-20 CN claimed
US-20210285938-A1 GASOTRANSMITTER METABOLITES AND ALZHEIMER'S DISEASE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2021-09-16 US claimed
WO-2015002612-A9 METHODS OF SCREENING USING INTERSTITIAL CELLS AND METHODS OF SUPPRESSING PROLIFERATION AND/OR TRANSFORMATION OF INTERSTITIAL CELLS SINGAPORE HEALTH SERVICES PTE LTD (SG) 2015-02-26 WO claimed
WO-2015002612-A1 METHODS OF SCREENING USING INTERSTITIAL CELLS AND METHODS OF SUPPRESSING PROLIFERATION AND/OR TRANSFORMATION OF INTERSTITIAL CELLS SINGAPORE HEALTH SERVICES PTE LTD (SG) 2015-01-08 WO claimed
US-8658570-B2 Use of anthranilamide derivatives for controlling insects and spider mites by drenching, soil mixing, furrow treatment, drip application, soil, stem or flower injection, in hydroponic systems, by planting hole treatment or dip application, floating or seedbox application or by treating seed, and also for enhancing the stress tolerance of plants to abiotic stress BAYER CROPSCIENCE AG (DE) 2014-02-25 US claimed
WO-2013050324-A1 COMBINATION, CONTAINING 4-PHENYLBUTYRIC ACID (4-PBA) OR A SALT THEREOF (COMPONENT (A)) AND ONE OR MORE SELECTED ADDITIONAL AGRONOMICALLY ACTIVE COMPOUNDS (COMPONENT(S) (B)), THAT REDUCES ABIOTIC PLANT STRESS BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-04-11 WO claimed
EP-0750489-B1 INHIBITION OF HAIR GROWTH HANDELMAN JOSEPH H (US) 1998-11-18 EP claimed
EP-0750489-A1 INHIBITION OF HAIR GROWTH HANDELMAN, Joseph H. (US) 1997-01-02 EP claimed
US-5455234-A Applying inhibitor of cysteine pathway enzyme topically to skin; cosmetic for face, arms, legs AHLUWALIA GURPREET S (US) 1995-10-03 US claimed
WO-1995024885-A1 INHIBITION OF HAIR GROWTH HANDELMAN, JOSEPH, H. (US) 1995-09-21 WO claimed
US-20260144252-A1 BROMINE- OR IODINE-PARA-SUBSTITUTED [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND THEIR SALTS, AGENTS FOR PROTECTING USEFUL PLANTS OR CROP PLANTS COMPRISING THEM, METHODS FOR PRODUCING THEM AND THEIR USE AS SAFENERS BAYER AKTIENGESELLSCHAFT (DE) 2026-05-28 US disclosed
US-20260138958-A1 SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES BAYER AG (DE) 2026-05-21 US disclosed
EP-4680598-A1 4-DIFLUOROMETHYL BENZAMIDES WITH HERBICIDAL ACTION Bayer Aktiengesellschaft (DE) 2026-01-21 EP disclosed
EP-4605378-A2 BROMINE- OR IODINE-PARA-SUBSTITUTED [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND THEIR SALTS, AGENTS FOR PROTECTING USEFUL PLANTS OR CROP PLANTS COMPRISING THEM, METHODS FOR PRODUCING THEM AND THEIR USE AS SAFENERS Bayer Aktiengesellschaft (DE) 2025-08-27 EP disclosed
EP-4605379-A1 BROMINE- OR IODINE-PARA-SUBSTITUTED [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND SALTS THEREOF, PROTECTION AGENTS COMPRISING THEM, FOR USEFUL PLANTS OR CROP PLANTS, METHODS FOR PRODUCING THEM AND USE THEREOF AS SAFENERS Bayer Aktiengesellschaft (DE) 2025-08-27 EP disclosed
WO-1995035318-A1 PLANT GENES FOR SENSITIVITY TO ETHYLENE AND PATHOGENS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1995-12-28 WO disclosed
US-5455234-A Applying inhibitor of cysteine pathway enzyme topically to skin; cosmetic for face, arms, legs AHLUWALIA GURPREET S (US) 1995-10-03 US disclosed
US-5444166-A ISOLATED NUCLEIC ACID SEQUENCE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1995-08-22 US disclosed
US-5367065-A Constitutive triple response gene and mutations THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1994-11-22 US disclosed
WO-1994003047-A1 CONSTITUTIVE TRIPLE RESPONSE GENE AND MUTATIONS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1994-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260138958-A1 SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES CBR1, CBR3, HDHD5 BLM 2818/4885PMP22 4423/4885HSD17B10 452/4885
US-20260144252-A1 BROMINE- OR IODINE-PARA-SUBSTITUTED [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND THEIR SALTS, AGENTS FOR PROTECTING USEFUL PLANTS OR CROP PLANTS COMPRISING THEM, METHODS FOR PRODUCING THEM AND THEIR USE AS SAFENERS CBR3, CBR1, CA3 BLM 3792/4885PMP22 4376/4885HSD17B10 1059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.